×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: Tauopathies
mechanism
4,072 words
KG: TAUOPATHIES
2026-03-24
kind:mechanism
section:mechanisms
state:published
Contents
Tauopathies
⚙
Mechanism Info
Name
Tauopathies
Summary
Classification and overview of tau protein-related neurodegenerative diseases
Key Genes/Proteins
MAPT
,
TAU
Knowledge Graph
Related Hypotheses (30)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc
Score: 0.60
GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl
Score: 0.58
TNF-α/IL-1β-Cx43 Hemichannel Axis as Upstream Link Between S
Score: 0.55
Microglial-Mediated Tau Clearance Dysfunction via TREM2 Sign
Score: 0.53
TREM2-Mediated Microglial Dysfunction Disrupts Perivascular
Score: 0.53
Heat Shock Protein 70 Disaggregase Amplification
Score: 0.51
Noradrenergic-Tau Propagation Blockade
Score: 0.51
Aquaporin-4 Polarization Rescue
Score: 0.51
Microglial Purinergic Reprogramming
Score: 0.48
Tau-Independent Microtubule Stabilization via MAP6 Enhanceme
Score: 0.48
Locus Coeruleus-Hippocampal Circuit Protection
Score: 0.48
Dual-Circuit Tau Vulnerability Cascade with Glial-Mediated A
Score: 0.46
TREM2-Mediated Microglial Dysfunction Disrupts Oligodendrocy
Score: 0.45
Neuronal Integrated Stress Response Modulation
Score: 0.45
Reelin-Mediated Cytoskeletal Stabilization Protocol
Score: 0.45
Sphingolipid Metabolism Reprogramming
Score: 0.44
LRP1-Dependent Tau Uptake Disruption
Score: 0.44
Astrocytic-Mediated Tau Clearance Dysfunction via TREM2 Sign
Score: 0.43
Glymphatic-Cholinergic Tau Clearance Cascade
Score: 0.43
VCP-Mediated Autophagy Enhancement
Score: 0.41
Glial Glycocalyx Remodeling Therapy
Score: 0.41
Ephrin-B2/EphB4 Axis Manipulation
Score: 0.40
Extracellular Vesicle Biogenesis Modulation
Score: 0.34
Show 25 more
Related Analyses (30)
Do tau strains or regional cellular environments primarily d
neurodegeneration · failed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Show 25 more
Related Experiments (24)
s:** - Compare tau strain spreading in EXT1/EXT2 conditional
falsification · proposed · Score: 0.40
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy
validation · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40
Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo
clinical · proposed · Score: 0.40
Tau Propagation Causality Test — Does Tau Spread Drive Neuro
clinical · proposed · Score: 0.40
Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.40
Tau ASO Therapy
validation · proposed · Score: 0.40
Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90
Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80
Mouse Cdk5, p35, and p39 mutations in neuronal migration
validation · proposed · Score: 0.80
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation
clinical · proposed · Score: 0.40
Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40
Show 19 more
See Also (5)
Tau Protein
protein · KG edge: causes
Tau Consortium
organization · KG edge: causes
TRIM11 Gene
gene · KG edge: protects_against
MAPT (Microtubule-Associated Protein Tau) Gene
gene · KG edge: implicated_in
DNAJB6 Gene
gene · KG edge: protects_against
Knowledge Graph (3 edges)
TAU
causes
TAUOPATHIES
MAPT
implicated_in
TAUOPATHIES
TAU
implicated_in
TAUOPATHIES